Charles River Laboratories | CRL - Capital Ordinaire





Capital Ordinaire Changement Date
Agilent USD 281.97M 252K 2026-06
Align Technology USD 71.04M 578K 2026-09
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Bruker USD 152.35M 130K 2026-06
Cardinal Health USD 232M 1000K 2026-09
Charles River Laboratories USD 47.88M 148K 2026-09
Cigna USD 264.6M 1.14M 2026-03
Concord Medical Services Hldg CNY 130.25M 0 2025-12
CVS Health USD 1.28B 2M 2026-09
Danaher USD 703.4M 500K 2026-09
Dentsply International USD 198.2M 1000K 2026-09
Elevance Health USD 216.11M 727K 2026-09
Humana USD 120.08M 18K 2026-06
Illumina USD 151.3M 607K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 164.8M 200K 2026-09
Laboratory Of America USD 81.2M 300K 2026-09
Lakefront Biotherapeutics EUR 65.66M 242K 2026-06
Lonza CHF 68.64M 0 2025-12
McKesson USD 115M 1000K 2026-09
Merck EUR 434.78M 0 2026-06
Mettler Toledo International USD 20.21M 40.9K 2026-06
Novartis USD 1.89B 12.09M 2026-09
Pfizer USD 5.7B 1000K 2026-09
Quest Diagnostics USD 110M 0 2026-09
Revvity USD 111.59M 43K 2026-09
Thermo Fisher Scientific USD 369.75M 1.88M 2026-09
United Therapeutics USD 42.38M 295K 2026-09
UnitedHealth USD 897.59M 10.55M 2026-09
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.19M 20K 2026-06
West Pharmaceutical Services USD 70.4M 500K 2026-06